B-PRECURSOR ALL
Clinical trials for B-PRECURSOR ALL explained in plain language.
Never miss a new study
Get alerted when new B-PRECURSOR ALL trials appear
Sign up with your email to follow new studies for B-PRECURSOR ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells show promise against tough childhood cancers
Disease control CompletedThis study tested a new treatment for children and young adults (ages 1-39) with B-cell leukemia or lymphoma that did not respond to standard therapy. The treatment involved taking a patient's own white blood cells, modifying them in a lab to target the CD22 protein on cancer cel…
Matched conditions: B-PRECURSOR ALL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New combo therapy offers hope for older leukemia patients
Disease control CompletedThis study tested a new treatment approach for adults over 55 with a specific type of leukemia (B-precursor ALL). The goal was to see if using a targeted drug called blinatumomab along with a reduced dose of chemotherapy could help patients achieve remission with fewer side effec…
Matched conditions: B-PRECURSOR ALL
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC